Suppr超能文献

相似文献

1
Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.
Environ Health Perspect. 2000 May;108 Suppl 2(Suppl 2):323-34. doi: 10.1289/ehp.00108s2323.
4
Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
J Toxicol Environ Health. 1997 Dec 26;52(6):475-515. doi: 10.1080/00984109708984077.
5
Alternatives for a risk assessment on chronic noncancer effects from oral exposure to trichloroethylene.
Regul Toxicol Pharmacol. 1996 Dec;24(3):269-85. doi: 10.1006/rtph.1996.0140.
7
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.
Environ Health Perspect. 2000 May;108 Suppl 2(Suppl 2):283-305. doi: 10.1289/ehp.00108s2283.
9
Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP).
Inhal Toxicol. 2005 Jun-Jul;17(7-8):317-34. doi: 10.1080/08958370590929394.
10
Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
Regul Toxicol Pharmacol. 1997 Feb;25(1):26-42. doi: 10.1006/rtph.1996.1070.

引用本文的文献

1
PBPK model-based gender-specific risk assessment of N-nitrosodimethylamine (NDMA) using human biomonitoring data.
Arch Toxicol. 2024 Oct;98(10):3269-3288. doi: 10.1007/s00204-024-03828-w. Epub 2024 Aug 3.
2
Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.
J Pharmacokinet Pharmacodyn. 2010 Dec;37(6):591-615. doi: 10.1007/s10928-010-9185-x. Epub 2010 Dec 14.
3
Interstrain differences in the liver effects of trichloroethylene in a multistrain panel of inbred mice.
Toxicol Sci. 2011 Mar;120(1):206-17. doi: 10.1093/toxsci/kfq362. Epub 2010 Dec 6.
4
Structures of aminoacylase 3 in complex with acetylated substrates.
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):17962-7. doi: 10.1073/pnas.1006687107. Epub 2010 Oct 4.
7
Molecular mechanism of trichloroethylene-induced hepatotoxicity mediated by CYP2E1.
Toxicol Appl Pharmacol. 2008 Sep 15;231(3):300-7. doi: 10.1016/j.taap.2008.04.020. Epub 2008 May 2.
8
Issues in the pharmacokinetics of trichloroethylene and its metabolites.
Environ Health Perspect. 2006 Sep;114(9):1450-6. doi: 10.1289/ehp.8691.
10

本文引用的文献

1
BEHAVIOURAL RESPONSE OF RATS DURING INHALATION OF TRICHLORETHYLENE AND CARBON DISULPHIDE VAPOURS.
Acta Pharmacol Toxicol (Copenh). 1964;21:36-44. doi: 10.1111/j.1600-0773.1964.tb01766.x.
2
Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario.
Environ Health Perspect. 2000 May;108 Suppl 2(Suppl 2):317-22. doi: 10.1289/ehp.00108s2317.
3
Cardiac teratogenicity of trichloroethylene metabolites.
J Am Coll Cardiol. 1998 Aug;32(2):540-5. doi: 10.1016/s0735-1097(98)00232-0.
4
A review: trichloroethylene metabolites: potential cardiac teratogens.
Environ Health Perspect. 1998 Aug;106 Suppl 4(Suppl 4):995-9. doi: 10.1289/ehp.98106s4995.
5
Onset of xenobiotic metabolism in children: toxicological implications.
Food Addit Contam. 1998;15 Suppl:45-51. doi: 10.1080/02652039809374614.
6
Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
J Toxicol Environ Health. 1997 Dec 26;52(6):475-515. doi: 10.1080/00984109708984077.
7
Alternatives for a risk assessment on chronic noncancer effects from oral exposure to trichloroethylene.
Regul Toxicol Pharmacol. 1996 Dec;24(3):269-85. doi: 10.1006/rtph.1996.0140.
8
Conversion of trichloroacetic acid to dichloroacetic acid in biological samples.
J Anal Toxicol. 1996 Jul-Aug;20(4):236-41. doi: 10.1093/jat/20.4.236.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验